AstraZeneca

Phone: +144 (0)20 3749 5000

E-mail: Medical.InformationUK@astrazeneca.com

Web:https://www.astrazeneca.com

Type Public limited company
Traded as LSE: AZN
FTSE 100 component
Nasdaq Stockholm: AZN
OMX Stockholm 30 component
Nasdaq: AZN
Nasdaq-100 component
ISIN  
Industry Pharmaceutical
Biotechnology
Predecessors
  • Astra AB
  • Zeneca Group plc
Founded 6 April 1999 (1999-04-06)
Headquarters 1 Francis Crick Avenue, Cambridge, UK
Area served Global
Key people Leif Johansson
(Chairman)
Pascal Soriot
(CEO)
Products Pharmaceutical products
Revenue Increase US$37.417 billion (2021)
Operating income Decrease US$1.056 billion (2021)
Net income Decrease US$0.115 billion (2021)
Total assets Increase US$105.363 billion (2021)
Total equity Increase US$39.287 billion (2021)
Number of employees 76,100 (2020)
Subsidiaries Alexion Pharmaceuticals
MedImmune
Website www.astrazeneca.com

We are a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide. Our purpose and values help explain why we exist, what we hope to accomplish, the behaviours we value, how we will achieve our goals, and the promise of our brand to our stakeholders.

For detailed contact information visit location pages below.

AstraZeneca's locations around the world

North AmericaExpand
OceaniaExpand

Clinical Trials sponsored by AstraZeneca

3